Pleiotropic effects of mutant huntingtin on retinopathy in two mouse models of Huntington's disease

Hui Xu1, Anakha Ajayan1, Ralf Langen1

  • 1Department of Physiology & Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Neurobiology of Disease
|December 30, 2024
PubMed

Insights

Huntington's disease (HD) pathology affects the retina, causing cell damage and visual deficits. The zQ175KI mouse model shows similar retinal defects to other models, indicating the eye

Area of Science:

  • Neuroscience
  • Genetics
  • Ophthalmology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the huntingtin gene.
  • Mutant huntingtin protein (mHTT) forms aggregates, leading to neuronal damage and cell death.
  • Retinal abnormalities and visual deficits are observed in HD patients and mouse models.

Purpose of the Study:

  • To investigate retinal pathology in the zQ175KI mouse model of Huntington's disease.
  • To compare retinal phenotypes between zQ175KI and R6/1 mouse models.
  • To explore the potential of the retina as a biomarker for HD progression and therapeutic testing.

Main Methods:

  • Histological analysis of retinal tissues from zQ175KI and R6/1 mice.
  • Immunohistochemistry to detect mHTT aggregates and signaling proteins.
  • Assessment of photoreceptor structure and cell polarity.

Main Results:

  • Similar retinal phenotypes were observed in zQ175KI and R6/1 mice, including mHTT aggregates, cone loss, and altered rod signaling.
  • Abnormally elongated photoreceptor connecting cilia and disrupted cell polarity in photoreceptor and retinal pigment epithelium (RPE) cells were identified.
  • mHTT nuclear inclusions were found in RPE cells of R6/1 mice.

Conclusions:

  • The zQ175KI mouse model exhibits retinal pathology relevant to Huntington's disease.
  • The eye displays mHTT-induced cellular disruptions, including polarity defects and non-neuronal inclusions.
  • The retina offers a potential avenue for monitoring HD progression and evaluating treatments.